预防二次缺血性中风的最新进展:叙述性综述
Yue Qiao1, Aminah I Fayyaz2, Yuchuan Ding2
1Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
二次性中风预防对于减少复发性缺血性中风事件至关重要. 最近的进展包括优化风险因素管理和新型疗法,如远程缺血症调节和素.
科学领域:
- 神经学 神经学
- 心脏病学 心脏病学
- 公共卫生 公共卫生
背景情况:
- 脑卒中是全球死亡和残疾的主要原因,重复性脑卒中特别严重.
- 二次性中风预防对于改善患者的治疗结果和降低死亡率至关重要.
- 近年来,预防复发性缺血性中风的策略取得了重大进展.
研究的目的:
- 在过去五年中,审查二次缺血性中风预防的最新进展.
- 突出关键的临床试验和创新干预措施,以减少中风复发.
- 讨论传统风险因素管理和新兴疗法的整合.
主要方法:
- 在过去5年中发表的临床试验和研究的文献综述.
- 分析抗血栓治疗的进展,心房的抗凝固药,以及风险因素管理目标.
- 评估新兴的治疗方法,包括远程缺血调节和抗炎药物.
主要成果:
- 精细的抗血栓治疗方案和直接口服抗凝剂改善了二次预防.
- 积极管理血压,脂质和葡萄糖进一步降低中风复发风险.
- 像远程缺血调节和素这样的新型干预措施在通过非传统途径预防中风复发方面表现有前途.
结论:
- 优化传统风险因素管理和新的治疗方法为二次中风预防提供了增强的选择.
- 未来的研究应该专注于个性化治疗策略和新型干预措施的临床应用.
- 需要继续进行研究,以充分理解和利用新兴治疗方法来减少中风复发.
更多相关视频
07:34Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
Published on: December 15, 2023
09:08Induction of Ischemic Stroke and Ischemia-reperfusion in Mice Using the Middle Artery Occlusion Technique and Visualization of Infarct Area
Published on: February 2, 2017
相关概念视频
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Preventive Healthcare Services
